Skip to content
Search

Latest Stories

Breakthrough cancer drug: Early study reveals pill's ability to annihilate all solid tumours

The drug underwent testing on 70 different cancer cell types in the laboratory, including breast, prostate, brain, ovarian, cervical, skin, and lung cancer

Breakthrough cancer drug: Early study reveals pill's ability to annihilate all solid tumours

Scientists have developed a groundbreaking cancer drug, codenamed AOH1996, that has the potential to kill all solid cancer tumours while leaving other cells unharmed.

The new molecule specifically targets a protein present in most cancers, which plays a crucial role in the growth and multiplication of tumours.


This protein, known as the proliferating cell nuclear antigen (PCNA), was previously considered "undruggable."

The drug underwent testing on 70 different cancer cell types in the laboratory, including breast, prostate, brain, ovarian, cervical, skin, and lung cancer, and demonstrated its effectiveness against all of them, the Daily Mail reported.

The drug's development was a result of 20 years of research conducted at the City of Hope Hospital in Los Angeles, one of America's leading cancer centres.

It is named after Anna Olivia Healey, a nine-year-old victim of neuroblastoma who inspired the research team to find a cure in her memory. The name of the drug comprises Anna's initials plus the date she was born.

Anna Cancer The drug is named after Anna Olivia Healey, a nine-year-old victim of neuroblastoma who inspired the research team to find a cure in her memory - Image Credit: Twitter

Dr Linda Malkas, the leader of the research team, had a profound encounter with Anna's father shortly before the young girl's passing. This meeting inspired her to dedicate her efforts to finding a cure for cancer in Anna's memory, who died in 2005.

While there is hope that this drug could revolutionise cancer treatment and potentially lead to cancer being curable within the next decade, it is currently in a Phase 1 clinical trial on humans at the City of Hope.

Dr Malkas, explained that the drug selectively disrupts DNA replication and repair in cancer cells without harming healthy cells.

This approach offers promising results as the drug can suppress tumour growth on its own or in combination with other cancer treatments without causing toxicity.

The research team discovered that PCNA plays a critical role in DNA replication and repair in cancer cells, making it an attractive target for therapy.

The new therapy focuses on a cancerous variant of PCNA, a protein that plays a critical role in DNA replication and repair within growing tumours.

In its mutated form, this protein is critical in DNA replication and repair of all growing tumours.

The therapy specifically targets this variant to combat the progression of cancer, making it a potential breakthrough in cancer treatment.

As of now, the results have been encouraging, showing potential for personalised and targeted cancer medicines.

Further research and clinical trials will be conducted to improve and understand the mechanism of action better.

The City of Hope Hospital has a history of pioneering translational research, leading to the development of lifesaving cancer drugs like trastuzumab, rituximab, and cetuximab.

More For You

Dr Punam Krishan: ‘My book inspires children to appreciate their bodies’

Dr Punam Krishan

Dr Punam Krishan: ‘My book inspires children to appreciate their bodies’

AN ASIAN doctor said she wants children to feel excited and empowered about their bodies when they read her new book.

Published last month, Dr Punam Krishan’s You & Your Body helps children and families understand the human body and make positive choices about well-being, the author said.

Keep ReadingShow less
Obesity drug
Boxes of Wegovy are seen at a pharmacy in London. (Photo: Reuters)

GPhC tightens rules for online obesity drug prescriptions

The General Pharmaceutical Council (GPhC), which oversees UK pharmacies, has introduced stricter rules for online pharmacies prescribing obesity drugs. The regulator said the changes aim to prevent individuals from receiving medicines that could pose health risks.

The new guidance, updated for the first time in three years, follows concerns about how some online pharmacies dispense weight-loss drugs.

Keep ReadingShow less
12 tricks to stick to your New Year’s resolutions and achieve your goals

Building habits gradually can lead to sustainable, long-term change

12 tricks to stick to your New Year’s resolutions and achieve your goals

Anjali Mehta

WHETHER it’s eating healthier, exercising more, saving money, or any number of goals, millions of people around the world make ambitious New Year’s resolutions.

Yet, by February, most of these well-intentioned plans are abandoned. If that sounds familiar, don’t worry – remember that it’s never too late to turn things around or set new goals.

Keep ReadingShow less
Getting set for a fitness journey

Bijan Azarmi

Getting set for a fitness journey

Bijan Azarmi

THE pressure to get fitter often discourages people from starting or causes them to give up soon after beginning. However, there are simple steps that can help navigate this challenging path toward better health through exercise.

With that in mind, Eastern Eye asked London-based fitness expert and personal trainer Bijan Azarmi to share his top tips for starting a physical health journey and staying motivated.

Keep ReadingShow less
Helpful hints for sticking with new year health goals

Build strength and confidence with consistent effort and support

Helpful hints for sticking with new year health goals

Jayeeta Dutta and Nesreen G

MANY adults aim to achieve a fitter version of themselves by the end of each year, yet studies show that almost two-thirds abandon their resolutions within the first month.

Sticking to a fitness routine can be challenging, especially for beginners, as distractions, easy alternatives, and daily life often get in the way.

Keep ReadingShow less